Verification of Imaging System PCD-1000A
NCT04024748 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2021-08-06
Summary
Scope Verification of technologies included in the PCD-1000A PET/CT imaging chain.
* Define and confirm all supported clinical protocols
* Evaluate performance
Conditions
- Cancer Patients
Interventions
- DEVICE
-
PET/CT imaging
Subjects will be have a PET/CT scan with PCD-1000A following their scheduled routine PET/CT scan. There will be no additional administration of radiopharmaceutical for the study.
Sponsors & Collaborators
-
Canon Medical Systems, USA
lead INDUSTRY
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-22
- Primary Completion
- 2019-11-26
- Completion
- 2019-11-26
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
NCT04442724 ·Status: RECRUITING ·Phase: NA
-
FDG PET-CT for Lymphoma Radiotherapy Planning Version 1.3
NCT01999998 ·Status: UNKNOWN ·Phase: NA
-
Feasibility Assessment of Next-generation PET Technology and Procedures
NCT03387618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Dual PET/CT Imaging in Lung Cancer
NCT01539928 ·Status: UNKNOWN
-
Demonstration of the "SPECT/CT System With CZT Detectors" Imaging Performance in a Clinical Setting
NCT03229772 ·Status: COMPLETED ·Phase: NA
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
Imaging Study for FdCyd and THU Cancer Treatment
NCT01479348 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid Tumors
NCT06383598 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of 18F-LNC1007 Injection PET/CT
NCT06471712 ·Status: COMPLETED ·Phase: PHASE1
-
PET-CT Imaging With PCD-CT
NCT07242690 ·Status: SUSPENDED ·Phase: NA
-
Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors
NCT05322512 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
MPDL3280A-imaging-IST-UMCG
NCT02453984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
NCT05436093 ·Status: RECRUITING ·Phase: NA
-
Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution
NCT04016818 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor
NCT05156515 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy
NCT05524454 ·Status: COMPLETED ·Phase: NA
-
Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction
NCT04417998 ·Status: COMPLETED ·Phase: PHASE4
-
CD147 Targeting Peptide Probe for PET Imaging in Solid Tumors
NCT06720298 ·Status: NOT_YET_RECRUITING
-
A Clinical Study of 68Ga-HX01 Injection for PET Imaging
NCT06416774 ·Status: COMPLETED ·Phase: PHASE1
-
Demonstration Of A Next Generation PET CT System
NCT05122715 ·Status: UNKNOWN ·Phase: NA
-
Ultralow Dose PET Imaging of 18F-FDG Uptake
NCT06956391 ·Status: RECRUITING ·Phase: PHASE2
-
Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors
NCT01632696 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
PD-L1 PET Imaging in Melanoma Patients
NCT03520634 ·Status: COMPLETED ·Phase: NA
-
Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device
NCT02331381 ·Status: TERMINATED ·Phase: PHASE1